Recent progress in rational drug design of neuraminidase inhibitors

被引：30

作者：

Liu, Yu ^{[1
]}

Zhang, Jie ^{[1
]}

Xu, Wenfang ^{[1
]}

机构：

[1] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Jinan 250012, ShanDong, Peoples R China

来源：

CURRENT MEDICINAL CHEMISTRY | 2007年 / 14卷 / 27期

关键词：

influenza virus; neuraminidase; neuraminidase inhibitor; pharmacophore model; antiviral agent; INFLUENZA-VIRUS NEURAMINIDASE; BEARING 4-GUANIDINO-NEU5AC2EN DERIVATIVES; POTENT ANTIINFLUENZA ACTIVITY; H5N1 AVIAN INFLUENZA; SIALIC-ACID ANALOGS; BENZOIC-ACID; STRUCTURAL-ANALYSIS; HIGHLY POTENT; ACTIVE-SITE; A VIRUSES;

D O I：

10.2174/092986707782360024

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Neuraminidase is a major glycoprotein of influenza virus which is essential for viral infection and offers a potential target for antiviral drug development. Rational drug design of NA inhibitors is now in the clinic and these molecules are effective and safe for the treatment of influenza. Recently, research of structure-based NA inhibitors is becoming an interesting field, leading to a breakthrough in the control of influenza. Here we review the progress in the rational drug design of NA inhibitors in recent years.

引用

页码：2872 / 2891

页数：20

共 50 条

[1] Recent progress and challenges in the discovery of new neuraminidase inhibitors
Chamni, Supakarn
De-Eknamkul, Wanchai
EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (04) : 409 - 423
[2] Rational drug design of orally active influenza neuraminidase inhibitors: Discovery and development of GS 4104
Kim, CU
MEDICINAL CHEMISTRY RESEARCH, 1998, 8 (7-8) : 392 - 399
[3] Recent progress in chemical approaches for the development of novel neuraminidase inhibitors
Mahal, Ahmed
Duan, Meitao
Zinad, Dhafer S.
Mohapatra, Ranjan K.
Obaidullah, Ahmad J.
Wei, Xiaoyi
Pradhan, Manoj K.
Das, Debadutta
Kandi, Venkataramana
Zinad, Hany S.
Zhu, Quanhong
RSC ADVANCES, 2021, 11 (03) : 1804 - 1840
[4] Progress with neuraminidase inhibitors
Fiddian, AP
REVIEWS IN MEDICAL VIROLOGY, 2000, 10 (02) : 135 - 137
[5] Progress in the Rational Design for Polypharmacology Drug
Zhou, Jinming
Li, Quanjie
Wu, Meng
Chen, Chao
Cen, Shan
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (21) : 3182 - 3189
[6] Recent Progress in the Discovery of Neuraminidase Inhibitors as Anti-influenza Agents
Rahim, Aisyah Saad Abdul
von Itzstein, Mark
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48, 2013, 48 : 249 - 263
[7] Recent Progress in the Design of Selectin Inhibitors
Chhabra, Siri Ram
Rahim, Aisyah S. Abdul
Kellam, Barrie
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2003, 3 (07) : 679 - 687
[8] RATIONAL DRUG DESIGN - THE PROTEINASE-INHIBITORS
WLODAWER, A
PHARMACOTHERAPY, 1994, 14 (06): : S9 - S20
[9] Neuraminidase inhibitors: Progress in the management of influenza
Woodhead, M
Lavanchy, D
Johnston, S
Colman, P
Fleming, D
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, 54 (09) : 604 - 610
[10] RECENT PROGRESS IN THE RATIONAL DESIGN OF PEPTIDE-HORMONES AND NEUROTRANSMITTERS
HRUBY, VJ
KRSTENANSKY, JL
CODY, WL
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 1984, 19 : 303 - 312

← 1 2 3 4 5 →